Author:
Ahmad Faizan,Karan Anik,Sharma Navatha Shree,Sundar Vaishnavi,Jayaraj Richard,Abiha Umme
Publisher
Springer Nature Singapore
Reference145 articles.
1. Agulla J, Brea D, Campos F, Sobrino T, Argibay B, Al-Soufi W, Blanco M, Castillo J, Ramos-Cabrer P (2014) In vivo theranostics at the peri-infarct region in cerebral ischemia. Theranostics 4(1):90–105
2. Ahmad N, Umar S, Ashafaq M, Akhtar M, Iqbal Z, Samim M et al (2013) A comparative study of PNIPAM nanoparticles of curcumin, demethoxycurcumin, and bisdemethoxycurcumin and their effects on oxidative stress markers in experimental stroke. Protoplasma 250(6):1327–1338
3. Ahmad N, Ahmad R, Naqvi AA, Alam MA, Ashafaq M, Samim M et al (2016) Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of cerebral ischemia. Int J Biol Macromol 91:640–655
4. Alavian F, Shams N (2020) Oral and intra-nasal administration of nanoparticles in the cerebral ischemia treatment in animal experiments: considering its advantages and disadvantages. Curr Clin Pharmacol 15(1):20–29
5. Alkaff SA, Radhakrishnan K, Nedumaran AM, Liao P, Czarny B (2020) Nanocarriers for stroke therapy: advances and obstacles in translating animal studies. Int J Nanomedicine 15:445–464